Parthasarathy Gopanandan, Kudva Yogish C, Low Phillip A, Camilleri Michael, Basu Ananda, Bharucha Adil E
Division of Gastroenterology and Hepatology, and.
Division of Endocrinology, Department of Internal Medicine, and.
J Clin Endocrinol Metab. 2017 Feb 1;102(2):398-406. doi: 10.1210/jc.2016-2809.
CONTEXT: In type 1 diabetes (T1D), delayed gastric emptying (GE) may predispose to a mismatch between insulin delivery and glucose absorption. Previous studies evaluated, only partly, the relationship between delayed GE and postprandial, but not diurnal, glycemia. OBJECTIVE: To assess the relationship between GE disturbances and glycemic control in T1D and the effects of accelerating GE on glycemic control. DESIGN, SETTING, AND PARTICIPANTS: This was a randomized placebo-controlled trial in 30 patients with T1D on an insulin pump at an academic medical center. INTERVENTION(S): GE was evaluated with a [13C]-Spirulina breath test at baseline (GEbaseline), during intravenous saline or erythromycin (2 or 3 mg/kg; GEiv), and after 7 days of oral erythromycin or placebo (GEoral). Weighed meals were provided throughout the study. MAIN OUTCOME MEASURE(S): These were GE and continuous glucose monitoring (CGM). RESULTS: The baseline glycosylated hemoglobin was 7.6% ± 0.8% (60 ± 8.7 mmol/mol); 12 patients (40%) had delayed GE; faster GE was associated with a greater postprandial CGM-based glucose, but slower GE was not associated with postprandial hypoglycemia (<70 mg/dL). Intravenous (3 mg/kg) but not oral erythromycin accelerated GE. The relationship between GE and glycemia differed between the postprandial periods and the entire day. After adjusting for carbohydrate intake and insulin consumption, faster GE was associated with more hyperglycemia during the postprandial period but lower glucose values across the entire study. CONCLUSIONS: In T1D, pharmacologically mediated acceleration of GE increases postprandial CGM-based glucose. In contrast, delayed GE is associated with greater CGM-based glucose values over the entire day.
背景:在1型糖尿病(T1D)中,胃排空延迟(GE)可能会导致胰岛素输注与葡萄糖吸收之间的不匹配。以往的研究仅部分评估了胃排空延迟与餐后血糖而非日间血糖之间的关系。 目的:评估T1D患者中胃排空障碍与血糖控制之间的关系,以及加速胃排空对血糖控制的影响。 设计、地点和参与者:这是一项在学术医学中心对30名使用胰岛素泵的T1D患者进行的随机安慰剂对照试验。 干预措施:在基线时(GE基线)、静脉输注生理盐水或红霉素(2或3mg/kg;GE静脉)期间以及口服红霉素或安慰剂7天后(GE口服),通过[13C] - 螺旋藻呼气试验评估胃排空。在整个研究过程中提供称重膳食。 主要观察指标:这些指标包括胃排空和连续血糖监测(CGM)。 结果:基线糖化血红蛋白为7.6%±0.8%(60±8.7mmol/mol);12名患者(40%)存在胃排空延迟;胃排空越快,基于CGM的餐后血糖越高,但胃排空越慢与餐后低血糖(<70mg/dL)无关。静脉注射(3mg/kg)而非口服红霉素可加速胃排空。胃排空与血糖之间的关系在餐后时段和全天有所不同。在调整碳水化合物摄入量和胰岛素消耗量后,胃排空越快,餐后时段的高血糖越明显,但在整个研究期间血糖值越低。 结论:在T1D中,药物介导的胃排空加速会增加基于CGM的餐后血糖。相比之下,胃排空延迟与全天基于CGM的更高血糖值相关。
J Clin Endocrinol Metab. 2017-2-1
J Clin Endocrinol Metab. 2018-6-1
Neurogastroenterol Motil. 2025-5
Aliment Pharmacol Ther. 2020-4-17
Curr Diab Rep. 2019-12-2
Gastroenterol Res Pract. 2019-9-9
Endocr Rev. 2019-10-1
World J Diabetes. 2018-11-15
JAMA. 2016-1-26
Clin Gastroenterol Hepatol. 2016-7
J Clin Endocrinol Metab. 2015-9
Gastroenterol Clin North Am. 2015-3
Am J Physiol Endocrinol Metab. 2014-7-29
Clin Gastroenterol Hepatol. 2013-4-30
Neurogastroenterol Motil. 2012-12-6